Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

The advent of artificial intelligence (AI) in healthcare is creating waves of innovation, transforming traditional medical practices. One of the ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH) is a disease that occurs when steatosis (a buildup of fat) in the liver causes liver inflammation and damage.

once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction associated steatohepatitis (MASH). FASCINATE-2, a Phase 2b clinical trial of denifanstat in MASH ...

However, steatosis can progress to nonalcoholic steatohepatitis ... with a liver biopsy being used when these less invasive tests are inconclusive. Summary and Conclusion Non-alcoholic fatty ...

While the evidence is mixed, it is clear that the relationship between alcohol use and stomach ulcers, or peptic ulcers, is complex. There’s little evidence to suggest that alcohol directly ...

The doctor will then send any removed polyps to a pathologist for a biopsy to see if cancer is present. If the biopsy reveals that cancer is present, then cancer specialists will outline a ...

Furthermore, comparison with metabolomics data of human metabolic dysfunction–associated fatty liver disease and metabolic dysfunction–associated steatohepatitis highlighted ... For liver biopsy ...